BrainSonix | Investor Info
BrainSonix has developed and intends to manufacture and market a medical device platform based on the Company’s proprietary Low Intensity Focused Ultrasound Pulse (“LIFUP”) technology to modulate the brain function non-invasively without any harmful or irreversible effects on the brain and body.
Low Intensity Focused Ultrasound Pulse, LIFUP, brain neuromodulation, deep brain stimulation, Repetitive Transcranial Magnetic Stimulation, Alexander Bystritsky, Woody Wurster, Mark Schafer, Alex Korb, BrainSonix, John Marlow
16933
page,page-id-16933,page-template,page-template-full_width,page-template-full_width-php,ajax_fade,page_not_loaded,,qode-theme-ver-7.5,wpb-js-composer js-comp-ver-4.5.3,vc_responsive
 

Investor Info

INVESTING IN THE FUTURE OF CHANGING LIVES

BrainSonix is an early-stage privately-held company.  For more information about the company, please contact Dr. Alexander (Sasha) Bystritsky at sasha@brainsonix.com or 818-584-8906.

investors